Crossref journal-article
Oxford University Press (OUP)
The Journal of Immunology (286)
Abstract

Abstract MRL/Mp-lpr/lpr (lpr) mice develop autoantibodies, vasculitis, and glomerulonephritis, which are similar to human systemic lupus erythematosus, and acquire a generalized, nonmalignant, lymphoproliferative disorder. CD4- CD8- CD3+ TCR alphabeta+ (double-negative, DN) T cells accumulate in spleen and lymph nodes, and become a major T cell population in vivo. These DN T cells, however, are refractory to various stimuli, including CD3, IL-2, CD28, PMA, and PHA. Recently, the lpr gene mutation has been identified as a mutant gene for Fas, resulting in expression defects of Fas Ag. It is still unclear, however, what kinds of mechanisms cause the dysfunction of lpr DN T cells. To elucidate the pathogenic mechanisms in abnormal DN T cells, biochemical analyses were conducted for the expression and tyrosine phosphorylation of the vav proto-oncogene product (Vav) in DN T cells from lpr mice. We demonstrated that Vav, a 95-kDa cytoplasmic protein, from lpr mice was constitutively tyrosine phosphorylated several times higher than in control +/+ mice, while expression of Vav protein in lpr and +/+ mice was equal. Additionally, in contrast with +/+ T cells, tyrosine phosphorylation of Vav, which normally increases within a minute of stimulation via TCR, did not increase in lpr DN T cells following PHA or Ab activation. Taken together with the suggested roles of Vav in multiple receptor-mediated signal transductions, our findings suggest that the functional abnormalities of lpr DN T cells may be related to Vav abnormal tyrosine phosphorylation, which could lead to impaired signaling between surface receptors and G proteins in this cell population.

Bibliography

Mimura, T., Minota, S., Nojima, Y., Morino, N., Hamasaki, K., Furuya, H., & Yazaki, Y. (1997). Constitutive tyrosine phosphorylation of the vav proto-oncogene product in MRL/Mp-lpr/lpr mice. The Journal of Immunology, 158(6), 2977–2983.

Authors 7
  1. T Mimura (first)
  2. S Minota (additional)
  3. Y Nojima (additional)
  4. N Morino (additional)
  5. K Hamasaki (additional)
  6. H Furuya (additional)
  7. Y Yazaki (additional)
References 0 Referenced 7

None

Dates
Type When
Created 2 years, 8 months ago (Dec. 30, 2022, 3:05 p.m.)
Deposited 8 months ago (Jan. 2, 2025, 12:16 p.m.)
Indexed 8 months ago (Jan. 3, 2025, 12:29 a.m.)
Issued 28 years, 5 months ago (March 15, 1997)
Published 28 years, 5 months ago (March 15, 1997)
Published Print 28 years, 5 months ago (March 15, 1997)
Funders 0

None

@article{Mimura_1997, title={Constitutive tyrosine phosphorylation of the vav proto-oncogene product in MRL/Mp-lpr/lpr mice.}, volume={158}, ISSN={1550-6606}, url={http://dx.doi.org/10.4049/jimmunol.158.6.2977}, DOI={10.4049/jimmunol.158.6.2977}, number={6}, journal={The Journal of Immunology}, publisher={Oxford University Press (OUP)}, author={Mimura, T and Minota, S and Nojima, Y and Morino, N and Hamasaki, K and Furuya, H and Yazaki, Y}, year={1997}, month=mar, pages={2977–2983} }